SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1319Marc ... No questions ... the subject matter is over my head ... However, thanJohn McCarthy-11/19/2004
1318Here's a first installment of a my rather comprehensive notes from the meetJMarcus-11/18/2004
1317Today's PR about Jonathan Wolter joining the company as CFO is set forth belJMarcus-11/18/2004
1316John, I just returned from the SH meeting. I forgot to ask you in advance if yoJMarcus-11/18/2004
1315FDA Accepts Supplemental New Drug Application Filing to Expand Namenda's(R) John McCarthy-11/15/2004
1314mop,This information is from the AXYX website and what excites me as to the poteArthur Radley-11/9/2004
1313IMO it has the potential of being a winner! Look back in recent spike in volume Arthur Radley-11/9/2004
1312axyx: Nope. Should I?mopgcw-11/9/2004
1311Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc. Tuesim1-11/9/2004
1310Mop, Have you ever looked at AXYX in this market niche?Arthur Radley-11/9/2004
1309Neurobiological Technologies, Inc. Reports First Quarter 2004-11-08 09:02 (New Ymopgcw-11/9/2004
1308Ebixa®, Lundbeck files for the mild to moderate indication for Alzheimer’s John McCarthy-10/21/2004
1307Forest sold $80 million worth of its Alzheimer's treatment Namenda, up from John McCarthy-10/4/2004
13062004 - Memantine May Be Effective for Mild to Moderate Alzheimer's Disease John McCarthy-9/16/2004
13052004 - Small (20 people) Lupus dementia clinical study .... Message 20530717 BJohn McCarthy-9/16/2004
13042004 - Memantine retards progression of Huntington's disease. Message 20507John McCarthy-9/10/2004
1303A couple insider buys: STUPPIN JOHN B,Director,BUYS 23,430 ON 8/26/04 OF NTII 2mopgcw-8/31/2004
1302Neurobiological Technologies Reports Fourth Quarter and Fiscal 2004 Financial Remopgcw-8/19/2004
1301Question about Ancrod ...... So that I can get to my question please assume thaJohn McCarthy-7/20/2004
1300FRX said in their CC that their Phase 2 DN trial has commenced. The treatment iJohn McCarthy-7/20/2004
1299Forest reports Namenda sales of $57,368,000 .... biz.yahoo.comJohn McCarthy-7/20/2004
1298Neurobiological Technologies Acquires Empire Pharmaceuticals, Further Expanding mopgcw-7/15/2004
1297<<Neurobiological Technologies, Inc. (NTI®) (NASDAQ: NTII) President JMarcus-5/12/2004
1296Neurobiological Technologies, Inc. Reports Third Quarter Results Monday May 10, mopgcw-5/10/2004
1295Widely used anti-nausea drug may interfere with cancer chemotherapy March 15, 2John McCarthy-4/29/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News